FridayDec 17, 2021 2:10 pm

ChineseNewsBreaks – FingerMotion Inc. (FNGR) Anticipates Early 2022 Operationalization of Its Latest Insurtech Services

FingerMotion (OTCQX: FNGR) is playing a part in the growth of insurtech, an industry that has turned 2021 into a record year for business with deals that have already outpaced all of 2020, by approximately 48%, as of the end of the third quarter. FingerMotion inked a big data outlook deal with global insurer Pacific Life early in the year to provide data analytics for Pacific Life’s Re-insurance division. The company also added two brands that will generate value-add underwriting services by covering mobile consumer device maintenance needs. “FingerMotion’s revenue generator is its mobile device tech services division, which grew…

Continue Reading

MondayNov 15, 2021 12:31 pm

ChineseNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Uniquely Positioned in Cancer Screening, Detection Market

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is the company behind a proprietary novel technology for early cancer screening and detection — the Cancer Differentiation Analysis (“CDA”). Powered by a database containing over 200,000 samples and cases, AnPac Bio’s CDA technology can detect and carry multifaceted information, including cellular and protein-level details, to determine the existence of cancerous environments. At present, the company’s CDA platform “can detect up to 26 different types of cancer, which gives AnPac Bio a major advantage over industry peers in terms of cost effectiveness, multi-cancer testing, ability…

Continue Reading

ThursdayNov 11, 2021 12:59 pm

ChineseNewsBreaks – FingerMotion Inc.’s (FNGR) Q2 Results Represent ‘Transition to Greater Profitability’

FingerMotion (OTCQX: FNGR), a communications and big data technology platform builder, recently released its Q2 results. “The China-focused enterprise reported quarterly revenue of $5.39 million, which included a 25% year-over-year quarterly growth in its short and multimedia messaging (‘SMS’ and ‘MMS’) business revenue of $0.73 million,” reads a recent article. According to CEO Martin Shen, the company is seeing unabated growth with SMS texting due to its optimized prepayments of bulk inventory purchases — the subscription plan and mobile phone sales contributed to this growth. FNGR is also seeing strong demand in SMS from its corporate clientele. “Despite the positive…

Continue Reading

ThursdayNov 04, 2021 11:11 am

ChineseNewsBreaks – Infobird Software Co. Ltd. (NASDAQ: IFBD) Helping Clients Increase Revenue, Reduce Costs, Enhance Customer Service

Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, empowers clients with business-driven solutions that help increase revenue, reduce costs and enhance customer service quality and satisfaction. With over ten years of experience providing customer engagement and SaaS for large enterprises in the finance industry, IFBD has a comprehensive customer engagement SaaS solutions portfolio that is highly intelligent, customizable, provides proof of stability and security at scale, and includes a concurrence of over 10,000 agents. Recently, the company extended its dedication and commitment to improving its offering by successfully expanding into the consumer and retail product providers market.…

Continue Reading

TuesdayNov 02, 2021 2:34 pm

ChineseNewsBreaks – FingerMotion Inc. (FNGR) Targeting Development of Innovative Insurtech, Fintech Products for Customers

FingerMotion (OTCQX: FNGR) launched its youngest operational division, Sapientus, in mid-2020 following years of R&D work. “In the past few years, we’ve had our inhouse team of actuaries and data scientists, who really know the ins and outs of the insurance industry, and what they’ve been doing is they’ve been deciphering information from all these different sources and putting in the risk metrics that could provide those fresh insights and intelligence for the insurance field,” a recent article quotes FingerMotion CEO Martin Shen as saying. “FingerMotion believes that by integrating its Sapientus data blocks with external data sources such as…

Continue Reading

FridayOct 29, 2021 1:36 pm

ChineseNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Leveraging CDA Technology for Critical Early Cancer Detection

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, since 2015 has commercially proven out its concepts through the development and sale of its cancer detection technology, Cancer Differentiation Analysis (“CDA”) for early detection of pre-cancerous disease and cancer. “The company has published numerous reports of clinical study results at major conferences, including ACSO conferences, and has been awarded over 100 patents globally. AnPac Bio is now able to make the claim that it is saving lives on a daily basis by detecting 26 different types of cancer very early, through the tens of…

Continue Reading

ThursdayOct 28, 2021 11:35 am

ChineseNewsBreaks – Infobird Software Co. Ltd. (NASDAQ: IFBD) in a League of Its Own

Infobird (NASDAQ: IFBD) is a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company that is constantly pushing the envelope with innovation and technology, further reinforcing its title as a company of firsts and also as the undisputed industry leader. IFBD has made a name for itself by leveraging proprietary next-generation technology, a product of years of research and development. “This has allowed it to stamp its position as a leader in the software-as-a-service (‘SaaS’) industry, particularly in the Chinese market,” reads a recent article. “Infobird is one of the very few companies in China to have built, from scratch, a customer…

Continue Reading

FridayOct 22, 2021 12:15 pm

ChineseNewsBreaks – AnPac Bio-Medical Science Co. Ltd.’s (NASDAQ: ANPC) Unique Platform Offering Comprehensive Blood Test Data, New Approach to Disease Screening

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, has developed the Cancer Differentiation Analysis (“CDA”) technology — a proprietary approach to detect cancerous and pre-cancerous diseases. “CDA uses the blood’s natural biophysical properties to identify cancerous environments before tumors even form. The CDA platform, in which technology is combined with protein-based biomarker tests to obtain even more comprehensive information, can be used to obtain more comprehensive data and information,” explains a recent article. “Unlike most liquid-based cancer screening and detection methods, the CDA platform from AnPac Bio focuses on assessing the existing protein-based…

Continue Reading

MondayOct 18, 2021 12:03 pm

ChineseNewsBreaks – FingerMotion Inc. (FNGR) Providing Corporate Clients with Standout Technology

FingerMotion (OTCQX: FNGR), a big data communications technology innovator, is focusing its new big data platform, Sapientus, on China’s insurance market. Speaking during an August corporate update conference call, FingerMotion CEO Martin Shen acknowledged that the company has also considered eventually focusing its big data platform on other industries beyond insurance and in markets beyond China’s borders. However, Shen indicated that the company will stay focused on its immediate purpose before expanding its reach. “FingerMotion launched its Big Data Insights division with its flagship database IP Sapientus last year and attracted global insurance behemoth Pacific Life Re-insurance as a client…

Continue Reading

MondayOct 11, 2021 1:41 pm

ChineseNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Stands Distinct in World of Cancer Prevention, Treatment

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, is a proven early thought leader and developer of multi-cancer (also called pan-cancer) ideas and technology. “AnPac Bio is one of the first companies in the world to produce major theories and methods of multi-level, multi-parameter and multi-cancer screening. The innovative technology has opened up a new field in early cancer screening that is based on a biophysical property and has achieved significant results,” reads a recent article. AnPac Bio has one of the largest sample libraries in the world, with more than 220,000 samples…

Continue Reading

Contact us: (310) 299-1717